Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.72494 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.77916 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69826 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.61476 | 29 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.6377 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.83171 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.87894 | 36 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.67149 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.85114 | 38 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.68288 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66487 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.63615 | 29 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.68554 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.68711 | 30 |